Big buys now coming in why ???19 May 2025 14:19
IMM RNS Summary – Strong Indications of a Big Deal on the Horizon
Key Points:
• IMM has made groundbreaking scientific progress with its P140 autoimmune platform.
• In early 2025, they announced major discoveries confirming:
• P140’s unique and non-immunosuppressive mechanism of action
• Its safety and effectiveness
• The ability to identify which patients will best respond to the treatment.
• These developments massively enhance the commercial appeal of P140 and have expanded the company’s IP portfolio, strengthening its value in partnership discussions.
Crucially:
• IMM is now in active discussions with multiple global commercial partners. This aligns perfectly with the enhanced clinical and IP data—ticking all the boxes for a licensing or partnership deal.
• The recent oversubscribed fundraise (£2.91m in Feb 2025) gives IMM some breathing room, suggesting they are preparing for a commercial transaction, not survival funding.
Conclusion:
This RNS quietly sets the stage for a transformational deal. With scientific proof in place, strengthened IP, and ongoing global partner talks, the company is clearly primed for a significant licensing or strategic partnership announcement.
Smart money is catching on , they waited for the drop as we all know how impatient PI are , this is the time to buy ..
The above is not financial advise ..